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In this study, we investigated in groups of female BALB/c mice injected with Crotalus durissus terriﬁcus venom (Cdt) the renal
function based on creatinine clearance, percentage of fractional excretion cytokines and histological examination of renal tissue.
Cdt causedrenalalterationsthatinducedproteinuriaduringtheinitialhourspost-venomandreducedcreatinineclearance15min.
upto2hourspost-venomadministration.InurinefrommiceinjectedwithCdt inducedadecreaseinIL-4levels.Morepronounced
increments of IL-5, IL-6 and IFN-γ were observed after 15 and 30min, respectively. The highest levels of TNF and IL-10 were
observed at 1 and 4hs, respectively. The ratios of pro- and anti-inﬂammatory cytokines in animals injected with Cdt, which may
bemanifestedintheinﬂammatorystatusduringtheenvenoming.IngroupsofanimalstreatedwithCdt wereobservedadecreasing
in creatinine clearance and its eﬀect on glomerular ﬁltration rate was accompanied by decreased fractional excretion of cytokines
and morphologic disturbances. This loss of change selectively in envenomation could thus explain why the relatively excretion of
cytokines is reduced while of total proteins increases. In conclusion the fractional excretion of cytokines is signiﬁcantly reduced in
mice injected with Cdt, despite proteinuria.
1.Introduction
Snake venom presents biological actions, chemical composi-
tion, toxicity, and pharmacokinetics and pharmacodynamic
characteristics and is a mixture of complex toxins such
as neurotoxins, myotoxins, coagulations, nephrotoxins, and
necrotoxins. It is important to understand that the actual
mix of toxins in the venom vary well by individual species
and also by age and season [1]. The Brazilian Crotalus
durissus terriﬁcus snake is responsible for many clinical cases
of envenoming. Its venom contains a variety of toxic proteins
including crotoxin, crotamine, gyroxin, convulsin, and a
thrombin-like enzymes [2, 3]. Envenomation caused by
Crotalus snake leads to serious complications and alterations
such as systemic hemorrhage, hepatotoxicity, myotoxicity,
hypotension, acute renal failure, and shock [4–7]. It has
been related to myolysis, hemolysis, hypotension, and/or
direct venom nephrotoxicity [7]. This venom has myotoxic
activity which leads to the development of rhabdomyolysis
that can be followed by skeletal muscle damage and the
release of creatinine phosphokinases, lactate dehydrogenase,
and myoglobin [8]. The pathogenesis of acute renal failure
aftersnakebitesappearstobemultifactorialsuchasbleeding,
hypotension, circulatory collapse, intravascular hemolysis,
dissemination intravascular coagulation, and also direct
nephrotoxicity of the venom [8, 9]. These eﬀects are deﬁned
as deterioration of renal function manifested by elevation
in blood urea nitrogen and serum creatinine, disturbances
in electrolyte and acid-base homeostasis, and retention
of nitrogenous waste products, occurring in hours or to
days and/or to weeks [9]. Acute renal failure is a frequent
complicationobservedinvictimsofsnakebites.Evaluationof
renal function parameters after crude venom administration
has suggested a direct eﬀect on glomerular ﬁltration rate, a
slowandsteadyaccumulationofnitrogenouswasteproducts,
and an inability of the kidney to regulate the balance of
sodium, electrolytes, acid, and water [10–13]. Gir´ on et al.
[14] demonstrated that the intravenous and intraperitoneal2 Mediators of Inﬂammation
administration of C. vegrandis crude venom induce damage
that encompasses the area of proximal tubules and peritubu-
larvesselsanddamagetotheglomerularcapillaryendothelial
cells as target of its action in absence of hemoglobin.
The kidney is the organ to help remove toxins, due to
its high blood ﬂow and its capacity to concentrate substance
in urine. Numerous in vitro and in vivo studies about renal
inﬂammation have been accompanied by a better under-
standing of the phenotypic changes and multifunctional
potentials of local and inﬁltrating cells within the site of
inﬂammation.Theseincludeactivation,transition,plasticity,
adhesion, traﬃcking of residential cells, and inﬁltrating
inﬂammatory cells such as neutrophils, monocytes/macro-
phages, and lymphocytes. These cells release inﬂamma-
tory mediators, which include diﬀerent sets of adhesion
molecules, proteases and degrading enzymes, oxygen free
radicals, nitric oxide, chemokines, growth factors, and dif-
ferent types of cytokines. Clinical and experimental animal
studies reveal that renal inﬂammation can be modulated by
inﬂammatory mediators [15, 16].
The purpose of the present study was to determine
the urinary cytokine levels in groups of mice treated with
diﬀerent amounts of Crotalus durissus terriﬁcus venom and
to examine the role of IL-6, IL-10, and TNF-α in the
pathogenesis of venom-induced acute renal failure. The
production of proinﬂammatory cytokines such as IL-6 and
TNF-α is responsible for initiation of an eﬀect against
exogenous stimulus. However, excessive production of these
mediators may signiﬁcantly contribute to shock, multi-
ple organ failure, and death [17–21]. In contrast, anti-
inﬂammatory cytokines such as IL-4 and IL-10 are crucial
for downregulating the increment inﬂammatory process and
maintaining homeostasis for the correct functioning of vital
organs [21, 22].
2.MaterialandMethods
2.1. Chemicals, Reagents, and Buﬀers. Actinomycin D, ortho-
phenyldiamine (OPD), fetal calf serum (FCS), and RPMI-
1640 medium were purchased from Sigma (St. Louis, Mo,
USA), murine anti-IL-4 (clones 11B11 and BVD6-24G2)
recombinant IL-4, murine anti-IL-5 (clones TRFK5 and
TRFK4), recombinant IL-5, murine anti-IL-6 (clones MP5-
20F3 and MP5-32C11), recombinant IL-6, murine anti-
IL-10 (clones JES5-16E3 and SXC-1), recombinant IL-10
and murine anti-IFN-γ (clones XGM1.2 and R4-6A2), and
recombinant IFN-γ were purchased from BD Biosciences
Pharmingen (USA), and recombinant TNF was purchased
from Boehringer Mannheim (Mannheim, Germany).
2.2. Venom. Lyophilized venom of Crotalus durissus terriﬁcus
(Cdt) was obtained from the Laboratory of Herpetology,
Instituto Butantan, SP, Brazil and stored at −20◦C. The
venom was dissolved in sterile physiological saline (0.85%
(w/v) NaCl solution) immediately before use.
2.3. Animals. Females BALB/c mice (6–8 weeks old, weigh-
ing 13 to 15g) were maintained in Bioterio-Facultad de
Medicina, UAEM (Cuernavaca, M´ exico). The animals were
maintained and used under strict ethical conditions accord-
ing to international recommendations for animal welfare the
Committee Members, International Society in Toxicology
[23].
2.4.LethalityAssay. Probitsmethodwasusedtocalculatethe
lethal dose ﬁfty (LD50)o ft h eCdt venom. The mice weighing
13 to 15g were intraperitoneally (i.p.) injected with 0.1mL
of various concentrations of venom, and the number of mice
diedwascountedafter48h.Thenumberofmiceusedateach
dose was four [24].
2.5. Blood and Urine Biochemical
2.5.1. Blood Collection. Groups of female BALB/c mice with
13–15g were injected intraperitoneously (i.p.) with diﬀerent
amounts of Cdt dissolved in 0.1mL of saline solution.
Control mice received 0.1mL of saline solution. Diﬀerent
times after injection with Cdt, animals were bled by retro-
orbitalplexus.Thebloodsampleswereallowedtostanduntil
they formed a clot, and the sera were used in biochemical
analysis [24].
2.5.2. Urine Collection. Mice were placed in metabolic cages
with ample water but no solid food. The animals were intra-
peritoneally injected with diﬀerent doses of Cdt venom,
and the urine was collected in a recovery tube on ice.
Mice produced an average of 0.05–0.100mL of urine/mouse
during diﬀerent times. After collection their urine was spun
to remove any solid debris and was stored at −70◦C until
batch ELISA cytokine measurements were performed.
2.5.3. Creatinine Levels. Present in sera and urine from con-
trol mice or injected with diﬀerent amounts of Cdt venom
were determined using speciﬁc kits (Spinreact diagnostic,
Sant Esteve de Bas, Spain), according to the manufacture’s
protocol [24].
2.5.4. Creatinine Clearance. Renal clearance (C)w a sc a l -
culated using the standard formula: C = (U × V)/
S(μL/min/100g) where U is urinary concentration, V is
urinary volume/min, and S is the serum creatinine levels for
each point.
2.5.5. Percentage of Fractional Excretions. Indicator clear-
ance rations were calculated using the formula: (Urinecre/
SerumX : UrineX/Serumcre) × 100, where X is cytokine
concentration (TNF, IL-6, IL-10, IL-4, and IFN-γ).
2.6. Proteins Assay. Total urine protein excretion was deter-
mined as previously described by Timoshanko and Tipping
[25]. In brief, mice were housed individually in cages to col-
lect urine before administration of Cdt, and spontaneously
voided urine was collected over diﬀerent times. Urine
samples were diluted in 1% 5-sulfosalicylic acid, and the
protein concentrations were determined spectrometrically atMediators of Inﬂammation 3
a wave length of 550nm and compared with known albumin
standards.
2.7. Mediators’s Production
2.7.1. Cytokines. The levels of cytokines IL-4, IL-5, IL-6, IL-
10, and IFN-γ present in urine from BALB/c mice were
assayed by a two-site sandwich enzyme-like immunosorbent
assay (ELISA) [26]. Brieﬂy, ELISA plates were coated with
100μL( 1 μg/mL) of the monoclonal antibodies anti-IL-6,
anti-IL-10, or anti-IFN-γ in 0.1M sodium carbonate buﬀer
( p H8 . 2 )a n di n c u b a t e df o r6 ha tr o o mt e m p e r a t u r e .T h e
wells were then washed with 0.1% phosphate-buﬀered saline
(PBS/Tween-20) and blocked with 100μL of 10% FCS in
PBS for 2h at room temperature. After washing, duplicate
urine samples of 50μL were added to each well. After 18h of
incubation at 4◦C, the wells were washed and incubated with
100μL( 2μg/mL) of the biotinylated monoclonal antibodies
anti-IL-4, anti-IL-5, anti-IL-6, anti-IL-10, or anti-IFN-γ as
second antibodies for 45min at room temperature. After
a ﬁnal wash, the reaction was developed by the addition
of OPD to each well. Optical densities were measured at
405nm in a microplate reader. The cytokine content of
each sample was read from a standard curve established
with the appropriate recombinant cytokines (expressed in
nanograms per milliliter). The minimum levels of each
cytokine detectable in the conditions of the assays were
10pg/mL for IFN-γ, IL-4, and IL-5 and 5pg/mL for IL-10
and IL-6.
To measure the cytotoxicity of TNF present in urine
samples, a standard assay with L929 cells, a ﬁbroblast
continuouscellline,wasusedasdescribedpreviouslybyRuﬀ
and Giﬀord [27]. The percentage cytotoxicity was calculated
as follows: (Acontrol − Asample/Acontrol) × 100. Titers were
calculated as the reciprocal of the dilution of the sample in
which 50% of the cells in the monolayers were lysed. TNF
activity is expressed as pg/mL estimated from the ratio of
a 50% cytotoxic dose of the test to that of standard mouse
recombinant TNF.
2.8. Histopathological Assay. After treatment both right and
left kidneys were ﬁxed in 10% paraformaldehyde/PBS (pH
7.4). The organs were embedded in paraﬃn, and sections
with thickness 4μm were cut by rotary microtome. The
slides were stained with hematoxylin and eosin (H & E) and
were examined with a light microscope using a 1 × 100 or
1 × 400lens. Images were captured with a coupled-device
camera and exported to Adobe Photoshop 7.0.
2.9. Statistical Analyzes. Data are expressed as the mean ±
standard deviation. Statistical analyses were performed by
Student’s t-test, and the level of signiﬁcance was set at P<
0.05.
3. Results
The eﬀects of diﬀerent doses of Crotalus durissus terriﬁcus
venom were analyzed by detecting the mortality and the
levels of proteins, creatinine, and cytokines in urine from
BALB/c female mice with 13–15g of body weight.
3.1. Eﬀect of Cdt on Lethality. We previously described that
1L D 50 for female BALB/c mice with 13–15g body weight
corresponds to 0.01mg/kg (data not shown). For groups of
animalsthatreceived0.5and1LD50 ofCdt,themortalitywas
0% and 50%, respectively, (data not shown). In contrast, for
the groups of mice injected with 2 and 2.5 LD50 of Cdt the
mortality observed was 90% and 100%, respectively, (data
not shown). Death was usually preceded by certain signals,
or symptoms were observed, and the highest mortality
percentage observed for groups of mice injected with 1 to 2.5
LD50 was between 4–6hs (data not shown).
3.2.EﬀectofDiﬀerentLD50 ofCdtonUrineProtein,Creatinine
Clearance, and Cytokines Production. I no r d e rt od e t e r m i n e
the levels of protein, creatinine clearance, and cytokines
present in urine, groups of mice were injected with diﬀerent
LD50 of Cdt venom for distinct times. As shown in Figure 1,
the levels of protein present in urine from mice treated with
Cdt were signiﬁcantly higher when compared with those
obtained in urine control mice, and these increments were
dose dependent (Figure 1). Creatinine clearance observed in
groups of mice treated with diﬀerent amounts of Cdt were
signiﬁcantly lower when compared with those obtained in
the control group (Figure 1). The ability of Cdt to induce
the production of cytokines levels is shown in Figure 2.
Among groups of mice treated with 0.5 LD50 of Cdt, the
urine levels of IL-4, IL-5, and IL-10 were signiﬁcantly higher
when compared with the control groups (P<0.001).
The urine levels of IL-6 and IFN-γ p r e s e n tf r o mm i c ei . p .
administrated with diﬀerent LD50 of Cdt were signiﬁcantly
lower than those obtained in urine from control groups
(Figure 2).Thedecreaseobservedforthesetwocytokineswas
dose-dependent. The highest levels of TNF were observed
for urine from mice injected with 1 and 2 LD50 (Figure 2).
Also was possible observing that with increment of venom
concentrationsthelevelsofIL-4,IL-5,IL-6,IL-10,andIFN-γ
were signiﬁcantly lower when compared with those obtained
in urine from control groups (P<0.0001).
3.3. Eﬀect of Cdt on Glomerular Filtration Rate. Taken these
results, it was possible to establish the evolution of in-
ﬂammatory and renal injury in mice treated with Cdt.T h u s ,
the following set of experiments to determine the eﬀect of
Cdt on renal function groups of BALB/c female mice with
13–15g of body weight were injected with 1 LD50 of Cdt for
diﬀerent time periods, and the urine was collected.
The time course of the presence of protein in urine from
mice injected with 1 LD50 of Cdt is shown in Table 1.T h e
amounts of protein started to appear after 15min in groups
of mice i.p. injected with Cdt. The maximum amounts of
protein were observed in urine from mice injected with Cdt
for 1h, decaying thereafter. At this time, the amounts of
protein present in urine from mice injected with Cdt were
signiﬁcantly diﬀerent when we compared those obtained in
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Figure 1: Protein present in urine and creatinine clearance. Groups of BALB/c female mice were injected i.p. with diﬀerent amounts of
Cdt for diﬀerent times as above described. The presence of protein in urine was determined by measuring the albumin. Creatinine levels
were detected in urine and serum from mice injected with diﬀerent amounts of Cdt for 1h. The formula to determine creatinine clearance
is described in Section 2. Each bar represents the mean value of samples from four experiments in diﬀerent groups of ﬁve mice. Statistical
diﬀerences between the treatments were (P>0.01).
Table 1: Time course of protein in urine and creatinine clearance.
Time of exposition to Cdt Protein Creatinine clearance
0 180 ±94 8 .48 ±1.11
1/4 220 ±12b 3.73 ± 0.11b
1/2 300 ±13b 3.47 ± 0.97b
1 350 ±18b 3.67 ± 0.11b
2 330 ±15b 3.62 ± 0.10b
4 300 ±10b 7.45 ± 0.23b
6 290 ±12b 13.88 ±0.36b
24 260 ±16a 40.00 ±1.16b
48 240 ±10a 39.80 ±1.31b
Groups of BALB/c female mice were injected i.p. with 1 LD50 of Cdt for
diﬀerent times as described in Section 2. The presence of protein in urine
wasdeterminedbymeasuringthealbumin.Thecreatinineclearanceinurine
was determined as above described. aNot signiﬁcant and bP<0.005.
of proteinuria had recovered considerably after 48hs. The
levels of creatinine started to increment 15min in groups of
mice injected with 1 LD50 of Cdt. Creatinine levels in urine
from mice injected with Cdt venom were signiﬁcantly higher
when compared with those obtained in control group (data
not shown). As shown in Table 1, the progressive decrease
in renal creatinine clearance was maximal 1-2hs postvenom
injection with return to basal levels after 48hs.
In Figure 3 is shown the kinetics of cytokines present
in urine. The levels of IL-4 present in urine from groups
of animals treated with Cdt were signiﬁcantly lower when
compared with those obtained from control groups (P<
0.001).IL-5levelspeakedafter15minofCdt administration,
decaying thereafter (Figure 3). The highest levels of IL-6
present in urine from mice injected with 1 LD50 Cdt were
observed after 30min, decaying thereafter (Figure 3). The
levels of TNF started to appear after 30min in urine from
mice injected with Cdt up to 2hs. The concentrations of
TNF present in urine were signiﬁcantly higher than those
obtained from urine from control group (P<0.0001).
Highest levels of IFN-γ in urine were observed 30min after
Cdt administration,decayingthereafter(Figure 3).Thelevels
of IL-10 in urine started to appear after 30min up to
4hs, decaying thereafter. The levels of this cytokine were
signiﬁcantly higher than those obtained from control mice
(P<0.0001) (Figure 3).
An imbalance of immune mediators together with an
inappropriate enhancement of proinﬂammatory cytokines
or even reduction of anti-inﬂammatory mediators has been
recognized to play an important role in the pathophysiology
of renal dysfunction. The ratios of pro-/anti-inﬂammatory
were calculated. The IFN-γ/IL-4, IFN-γ/IL-10, and IL-6/IL-
10 ratios increased gradually, reaching their highest at 15
and 30min, respectively, and decaying thereafter (Figure 4).
The highest TNF/IL-10 ratios were observed at 1h after Cdt
administration (Figure 4).
The fractional excretion of a substance represents the
proportion of the substances excreted in the urine compared
with that ﬁltered by the glomeruli. Calculations of fractional
excretion help to understand whether increased serum levels
of an analytic are due to increased production or decreased
excretion. In this study, the fractional excretion of cytokines
measured of the percentage of cytokine excreted in the
urine versus the cytokine reabsorbed by the kidney was
determined. It is measured in terminus of serum and urine
cytokine. We previously described the presence of IL-4, IL-5,
IL-6, TNF, IFN-γ, and IL-10 in serum from female BALB/c
mice injected with Cdt [24]. The fractional excretion of
cytokine was calculated as a part of the evaluation of acute
renal failure. The percentage of fractional excretion of IL-
4a n dI F N - γ was reduced in groups of animals treated for
30min (Figure 5). Fractional excretion of IL-6 was reducedMediators of Inﬂammation 5















































































































Figure 2: Cytokine excreted in urine from BALB/c female mice. Urine of mice was obtained after i.p. injection with diﬀerent amounts of
Cdt as above described. The levels of IL-5 were determined after 15min, for IL-4, IL-6, IL-10, and IFN-γ after 1h. They were assayed by
ELISA assay using monoclonal antibodies as the probe. TNF levels were determined after 1h by standard assay with L929 cells. Each bar
represents the mean value of samples from four experiments in diﬀerent groups of ﬁve mice. Statistical diﬀerences between the treatments
were (P>0.01).
in group of animals treated for 15min with Cdt (Figure 5).
The percentage of fractional excretion of TFN-α was similar
to control up to 1h post-Cdt administration. As shown
in Figure 5, the percentage of fractional excretion of TNF-
α was signiﬁcantly reduced in groups of animals treated
with Cdt for 1 up to 2hs. With respect to the percentage
of fractional excretion of IL-10, the high percentage was
observed after 1h of Cdt administration, decaying thereafter
(Figure 5).Percentagesoffractionalexcretionofallcytokines
had recovered considerably after 48hs.6 Mediators of Inﬂammation













































































































Figure 3: Kinetics of cytokines. Groups of BALB/c female mice were injected i.p. with 1 LD50 of Cdt for diﬀerent times as above described.
ThelevelsofcytokinesexcretedinurineandserumweredeterminedasdescribedinSection 2.Eachbarrepresentsthemeanvalueofsamples
from four experiments in diﬀerent groups of ﬁve mice. Statistical diﬀerences between the treatments were (P>0.01).
3.4. Eﬀect of Cdt on Renal Injury. To evaluate the renal
injury, groups of mice injected with 1 LD50 of Cdt for
diﬀerent intervals of time were sacriﬁced, and the kidneys
were histologically examined. The degree of renal injury was
graded semiquantitatively in at least 30 cross-sections per
mice according to the following characteristics: glomerular
lesions, tubular vacuolization, tubular dilation, tubular
necrosis, and leukocyte inﬁltration. Histological evaluation
of kidneys from groups of mice injected with Cdt is shown in
Figure 6. The histological evaluation of kidneys from control
groups revealed good preservation (data not shown). Cdt
injection resulted in diﬀuse renal changes characterized by
severe tubular injury with principal observation in tubular
dilation and cast formation throughout the cortex, moderateMediators of Inﬂammation 7
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Figure 4: Balance pro-/anti-inﬂammatory. The urine levels of cytokines were determined as described in Section 2.T h er a t i o sI F N - γ /IL-4,
IFN-γ/IL-10, IL-6/IL-10 and TNF/IL-10 represent the values of samples from two experiments in diﬀerent groups of ﬁve mice.
extra capillary, glomerular hypercellularity, mesangial ex-
pansion, and increased glomerular size (Figure 6). The
degenerative changes were seen in the proximal tubules at
4hs after venom injection. These changes considered a loss
of proximal brush border, cytoplasmic vacuolation, and in
some tubules, degeneration and desquamation of necrotic
cells.
4. Discussion
In Brazil, Crotalus durissus terriﬁcus is responsible for the
majority of accidents among humans. The etiology of
Crotalus venom-induced acute renal failure in humans and
experimental animals is still not completely understood but
probably involves a direct action of venom components on
renal tubules and renal epithelial cells. The pathogenesis of
acute renal failure induced by Crotalus venom is multifac-
torial. It has been associated to direct nephrotoxicity with
absence of systemic factors as well as to rhabdomyolysis
with the subsequent release of myoglobin from damaged
skeletal muscle into serum and urine that are potentially
nephrotoxic, leading to acute tubular necrosis [28–31].
In order to establish the optimal conditions for renal
inﬂammation-venom interactions, the eﬀects of Cdt on
levels of proteins, creatinine, and cytokine excreted in urine
were studied. This study shows that after Cdt injection
was observed an increasing of proteins in urine, and
these changes were dose dependent of the venom used.
Acute renal failure is a clinical entity characterized by a
sharp reduction in the glomerular ﬁltration rate and can
result from a variety of renal injuries [32]. We previously
described the presence of creatinine in serum [24], a
combination of blood and urine creatinine levels may be
used to calculate a creatinine clearance. In this study we
demonstrated that the creatinine clearance was reduced in
groups of mice treated with Cdt for 2h with return to
the basal levels after 48h. These results are in accordance
with other authors who have described that after enven-
omation with snake from Crotalus and Bothrops genera
presented reversible alterations in renal function [29, 32,
33].
Thecytokinesplaycriticalrolesininitiationandmodula-
tion of renal inﬂammatory responses through their ability to
modulatetheThelper1/Thelper2balancesofnephritogenic
immune responses. T cells actively participate in renal8 Mediators of Inﬂammation
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Figure 5: Percentage of fractional excretion of cytokines. Groups of BALB/c female mice were injected i.p. with 1 LD50 of Cdt for diﬀerent
times as above described. The percentage of fractional excretion was determined as described in Section 2. Each point represents the mean
value of samples from four experiments in diﬀerent groups of ﬁve mice. Statistical diﬀerences between the treatments were (P>0.01).
injury and are mainly with Th1 phenotype and produce
TNF-α and IFN-γ [34–36]. The contribution of Th1 cells in
renal pathology has been well described in T-cell-deﬁcient
animals, which lack a transcription factor promoting Th1
cells diﬀerentiation [37, 38]. The renal inﬂammation such
as glomerulonephritis and tubulo-interstitial nephritis can
occur either as an isolated local acute inﬂammatory reaction
or as part a systemic inﬂammatory disorders, which usually
resultsininterstitialﬁbrosis,tubularatrophy,andglomerular
if not treated or spontaneously repaired. InﬂammatoryMediators of Inﬂammation 9
(a) (b)
Figure 6: Histological assays. Groups of BALB/c female mice were injected i.p. with 1 LD50 of Cdt for diﬀerent times as above described. The
levels of cytokines excreted in urine were determined as described in Section 2. Each point represents the mean value of samples from four
experiments in diﬀerent groups of ﬁve mice. Statistical diﬀerences between the treatments were (P>0.01).
mediators produced and secreted at ﬁrst hours can induce
organ failure and damage. In the present study we observed
the acute renal failure in mice injected intraperitoneally with
1L D 50 of venom that permitted surgery and physiological
measurements in survivor animals. In addition, with this
dose of Cdt, it was possible to evaluate renal function. At
30min, envenomation resulted in an elevation in urine IL-
6, IFN-γ, TNF, and IL-10 concentration. Renal clearances
of creatinine were determined at 1-2h following a Cdt
administration. The glomerular failure rate decreased signif-
icantly2hafterthevenomadministration.IL-6iscommonly
induced together with other inﬂammatory cytokines that
could aﬀect IL-6 signaling and its biological eﬀects [38]. In
accord,IL-1β,TN F - α, and IL-10 interfere with IL-6signaling
and decreased its anti-inﬂammatory eﬀects [38]. Therefore,
the function of IL-6 as a pro- or anti-inﬂammatory cytokine
is also related to the presence or absence of other inﬂam-
matory cytokines. Under the conditions used in the present
study, we observed that the injection with Cdt may alter
cytokine production. The levels of IL-6 and IFN-γ present
in urine were decreasing in a dose-dependent manner. By
contrast, the highest levels of IL-4, IL-5, and IL-10 were
obtained in groups of mice injected with 0.5 LD50 of Cdt.
The highest levels of TNF were observed in groups of mice
injected with 1 LD50.
Studies aimed to evaluate the role of the kidney in clear-
ance of the inﬂammatory cytokines of septic patients reveal
that the kidney removes some proinﬂammatory cytokines
from plasma at the onset of the disease as long as diuresis is
maintained [39]. However, in advanced sepsis characterized
by acute renal and oliguria, the fractional excretion of
severalinﬂammatorycytokinesdrops,and,asaconsequence,
their plasma concentration rises [40]. In humans, the role
of the kidney in controlling cytokines homeostasis is well
established [40]. The kidney preferentially ﬁlters smaller
proinﬂammatory molecules such as <20kDa and less readily
ﬁlters the larger anti-inﬂammatory cytokines that present
>20kDa and soluble cytokines receptors [41]. In this study
we show that, among cytokines, TNF-α and IL-10 were
secreted at high and low levels in urine, respectively.
Moreover, the ﬁltered proinﬂammatory cytokine, are not
excreted intact in the urine but are absorbed in the proximal
renal tubules and denatured by intracellular proteolytic
mechanisms [42].
The ratios of pro-/anti-inﬂammatory cytokines indicate
the inﬂammatory status of the cells. The results obtained
in this study showed the balance between pro- and anti-
inﬂammatory cytokines in urine, which may represent
inﬂammatory status in envenoming processes up to 4
hours after Cdt administration. Based on these ﬁndings
with low levels of anti-inﬂammatory cytokines and high
levels of proinﬂammatory cytokines that are associated
with increased mortality, it seems evident that the bal-
ance between pro- and anti-inﬂammatory cytokines was
associated with organ function, which was evaluated by
measuring kidney function. Therefore, creatinine levels in
blood and urine may be used to calculate the creatinine
clearance which reﬂects the glomerular ﬁltration rate that
is clinically important because it is a measurement of
renal function. Obstruction of the upper urinary tract has
deleteriouseﬀectsonthekidneyandisanimportant causeof
renal insuﬃciency in humans. In this study the histological
analysis of kidneys from envenomated mice revealed that
rupture and desquamation of renal tubule epithelium into
the tubule lumen could contribute to proteinuria. Changes
initially observed in renal function are reversible; however,
with sustained injury these histological alterations translate
intoapermanentlossinrenalfunction[43].Thedetectionof
B.alternatusvenomin glomerularandinproximal anddistal
renal tubules agreed with the morphological and histological
damage caused by the venom in these anatomical regions
and indicated that there was a close correlation between
the sites of venom localization and subsequent damage
[33].
In conclusion, our results demonstrate that, in collected
urine from mice injected with Cdt, the levels of cytokines
were decreased when compared to those in control groups.
Thecellularlocalizationofthevenomanditskineticsinrenal
tissue agreed with various venom-induced morphological
and functional alterations.10 Mediators of Inﬂammation
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